Sandra Calvin

SVP, CHIEF ACCOUNTING OFFICER

SVP, CHIEF ACCOUNTING OFFICER at Travere Therapeutics, Inc., filing insider transactions on 2026-09-15.

Total Purchases

—

0 transactions

Total Sales

$335K

3 transactions

Companies Traded

3 total filings

Active Since

2026-09-15

Last: 2026-09-15

Companies

Travere Therapeutics, Inc.

Date	Ticker	Type	Shares	Price	Value	Owned After
2026-09-15	TVTX	Sale	300	$63.66	$19K	42.4K	SEC ↗
2026-09-15	TVTX	Sale	4,275	$62.13	$266K	43.5K	SEC ↗
2026-09-15	TVTX	Sale	800	$62.85	$50K	42.7K